Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004806:Ependymoma / Q000150:complications / Q000188:drug therapy*; D005910:Glioma / Q000150:complications / Q000188:drug therapy*; D007267:Injections; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000150:complications / Q000188:drug therapy; D009603:Nitroso Compounds / Q000627:therapeutic use*; D013223:Statistics as Topic; D014508:Urea / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D009603:Nitroso Compounds; D003520:Cyclophosphamide; D014508:Urea; D008727:Methotrexate